| Sep 13 |
Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for Multiple Types of Cancer
|
| Sep 10 |
Q1 2025 Avid Bioservices Inc Earnings Call
|
| Sep 6 |
Why Is Sarepta Therapeutics (SRPT) Down 1.9% Since Last Earnings Report?
|
| Sep 5 |
Halozyme Therapeutics (HALO) Up 14.8% Since Last Earnings Report: Can It Continue?
|
| Sep 2 |
Why Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term
|
| Aug 28 |
Halozyme to Present at Upcoming Investor Conferences
|
| Aug 28 |
Exploring Three High Growth Tech Stocks in the United States
|
| Aug 26 |
Top 2 Health Care Stocks That May Plunge In August
|
| Aug 23 |
Halozyme Earnings, Guidance Point to Bullish Future
|
| Aug 20 |
How Is The Market Feeling About Halozyme Therapeutics?
|
